{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:37:53Z","timestamp":1788280673103,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:00:00Z","timestamp":1601078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:00:00Z","timestamp":1601078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00408-020-00394-7","type":"journal-article","created":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T14:03:38Z","timestamp":1601129018000},"page":"917-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The St. George\u2019s Respiratory Questionnaire in Pulmonary Sarcoidosis"],"prefix":"10.1007","volume":"198","author":[{"given":"K. H.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. S.","family":"Barnathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-3862","authenticated-orcid":false,"given":"R. P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Sarcoidosis T-48 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,26]]},"reference":[{"key":"394_CR1","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/j.lpm.2012.03.019","volume":"41","author":"RP Baughman","year":"2012","unstructured":"Baughman RP, Lower EE, Gibson K (2012) Pulmonary manifestations of sarcoidosis. Presse Med 41:e289\u2013e302","journal-title":"Presse Med"},{"issue":"9","key":"394_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/00007611-199709000-00010","volume":"90","author":"KB Highland","year":"1997","unstructured":"Highland KB, Retalis P, Coppage L, Schabel SI, Judson MA (1997) Is there an anatomic explanation for chest pain in patients with pulmonary sarcoidosis? South Med J 90(9):911\u2013914","journal-title":"South Med J"},{"issue":"1","key":"394_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","volume":"68","author":"AS Patel","year":"2013","unstructured":"Patel AS, Siegert RJ, Creamer D, Larkin G, Maher TM, Renzoni EA et al (2013) The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status. Thorax 68(1):57\u201365","journal-title":"Thorax"},{"issue":"3","key":"394_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1378\/chest.125.3.997","volume":"125","author":"CE Cox","year":"2004","unstructured":"Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA (2004) Health-related quality of life of persons with sarcoidosis. Chest 125(3):997\u20131004","journal-title":"Chest"},{"issue":"11","key":"394_CR5","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.rmed.2008.05.001","volume":"102","author":"BS Gvozdenovic","year":"2008","unstructured":"Gvozdenovic BS, Mihailovic-Vucinic V, Ilic-Dudvarski A, Zugic V, Judson MA (2008) Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir Med 102(11):1636\u20131642","journal-title":"Respir Med"},{"issue":"5","key":"394_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/MCP.0b013e3283050a4f","volume":"14","author":"DE Victorson","year":"2008","unstructured":"Victorson DE, Cella D, Judson MA (2008) Quality of life evaluation in sarcoidosis: current status and future directions. Curr Opin Pulm Med 14(5):470\u2013477","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"394_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ccm.2008.03.012","volume":"29","author":"RP Baughman","year":"2008","unstructured":"Baughman RP, Costabel U, du Bois RM (2008) Treatment of sarcoidosis. Clin Chest Med 29(3):533\u2013548","journal-title":"Clin Chest Med"},{"issue":"4","key":"394_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1055\/s-0030-1262209","volume":"31","author":"G Keir","year":"2010","unstructured":"Keir G, Wells AU (2010) Assessing pulmonary disease and response to therapy: which test? Semin Respir Crit Care Med 31(4):409\u2013418","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"394_CR9","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","volume":"145","author":"PW Jones","year":"1992","unstructured":"Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory questionnaire. Am Rev Respir Dis 145(6):1321\u20131327","journal-title":"Am Rev Respir Dis"},{"issue":"2 Pt 1","key":"394_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","volume":"156","author":"CB Wilson","year":"1997","unstructured":"Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R (1997) Validation of the St. George's respiratory questionnaire in bronchiectasis. Am J Respir Crit Care Med 156(2 Pt 1):536\u2013541","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"394_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1378\/chest.116.5.1175","volume":"116","author":"JA Chang","year":"1999","unstructured":"Chang JA, Curtis JR, Patrick DL, Raghu G (1999) Assessment of health-related quality of life in patients with interstitial lung disease. Chest 116(5):1175\u20131182","journal-title":"Chest"},{"issue":"2","key":"394_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/rheumatology\/kel221","volume":"46","author":"L Beretta","year":"2007","unstructured":"Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R (2007) Validity of the Saint George's respiratory questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology (Oxford) 46(2):296\u2013301","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"394_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.rmed.2009.09.006","volume":"104","author":"JJ Swigris","year":"2010","unstructured":"Swigris JJ, Brown KK, Behr J, du Bois RM, King TE, Raghu G et al (2010) The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 104(2):296\u2013304","journal-title":"Respir Med"},{"issue":"2","key":"394_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000029480","volume":"67","author":"K Stavem","year":"2000","unstructured":"Stavem K, Bjortuft O, Lund MB, Kongshaug K, Geiran O, Boe J (2000) Health-related quality of life in lung transplant candidates and recipients. Respiration 67(2):159\u2013165","journal-title":"Respiration"},{"issue":"6","key":"394_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ejim.2006.02.024","volume":"17","author":"KM Antoniou","year":"2006","unstructured":"Antoniou KM, Tzanakis N, Tzouvelekis A, Samiou M, Symvoulakis EK, Siafakas NM et al (2006) Quality of life in patients with active sarcoidosis in Greece. Eur J Intern Med 17(6):421\u2013426","journal-title":"Eur J Intern Med"},{"issue":"4","key":"394_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5588\/ijtld.12.0665","volume":"17","author":"BS Gvozdenovic","year":"2013","unstructured":"Gvozdenovic BS, Mihailovic-Vucinic V, Vukovic M, Lower EE, Baughman RP, Dudvarski-Ilic A et al (2013) Effect of obesity on patient-reported outcomes in sarcoidosis. Int J Tuberc Lung Dis 17(4):559\u2013564","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"394_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1378\/chest.06-2822","volume":"132","author":"RP Baughman","year":"2007","unstructured":"Baughman RP, Sparkman BK, Lower EE (2007) Six-minute walk test and health status assessment in sarcoidosis. Chest 132(1):207\u2013213","journal-title":"Chest"},{"key":"394_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1164\/rccm.200211-1343OC","volume":"168","author":"CE Cox","year":"2003","unstructured":"Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA (2003) The sarcoidosis health questionnaire. A new measure of health-related quality of life. Am J Resp Crit Care Med 168:323\u2013329","journal-title":"Am J Resp Crit Care Med"},{"key":"394_CR19","first-page":"110","volume":"26","author":"RP Baughman","year":"2009","unstructured":"Baughman RP, Judson MA, Lower EE, Highland K, Kwor S, Craft N et al (2009) Inhaled iloprost for sarcoidosis associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis 26:110\u2013120","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"394_CR20","first-page":"139","volume":"28","author":"MA Judson","year":"2011","unstructured":"Judson MA, Highland KB, Kwon S, Donohue JF, Aris R, Craft N et al (2011) Ambrisentan for sarcoidosis associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis 28(2):139\u2013145","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"7","key":"394_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, Du BR et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174(7):795\u2013802","journal-title":"Am J Respir Crit Care Med"},{"key":"394_CR22","first-page":"377","volume":"14","author":"G Borg","year":"1982","unstructured":"Borg G (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377\u2013381","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"394_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1183\/09031936.00051907","volume":"31","author":"MA Judson","year":"2008","unstructured":"Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS et al (2008) Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 31(6):1189\u20131196","journal-title":"Eur Respir J"},{"issue":"1","key":"394_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159(1):179\u2013187","journal-title":"Am J Respir Crit Care Med"},{"key":"394_CR25","first-page":"90","volume":"29","author":"RP Baughman","year":"2012","unstructured":"Baughman RP, Drent M, Culver DA, Grutters JC, Handa T, Humbert M et al (2012) Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 29:90\u201398","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"6","key":"394_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.rmed.2004.10.018","volume":"99","author":"SA Papiris","year":"2005","unstructured":"Papiris SA, Daniil ZD, Malagari K, Kapotsis GE, Sotiropoulou C, Milic-Emili J et al (2005) The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med 99(6):755\u2013761","journal-title":"Respir Med"},{"issue":"1","key":"394_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111\u2013117","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"394_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473\u2013483","journal-title":"Med Care"},{"issue":"3","key":"394_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","volume":"31","author":"CA McHorney","year":"1993","unstructured":"McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31(3):247\u2013263","journal-title":"Med Care"},{"issue":"9356","key":"394_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","volume":"361","author":"P Calverley","year":"2003","unstructured":"Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A et al (2003) Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 361(9356):449\u2013456","journal-title":"Lancet"},{"issue":"2","key":"394_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/thx.2009.113498","volume":"65","author":"JJ Swigris","year":"2010","unstructured":"Swigris JJ, Wamboldt FS, Behr J, du Bois RM, King TE, Raghu G et al (2010) The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax 65(2):173\u2013177","journal-title":"Thorax"},{"issue":"5","key":"394_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1513\/pats.200802-020SK","volume":"5","author":"H Chen","year":"2008","unstructured":"Chen H, Taichman DB, Doyle RL (2008) Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension. Proc Am Thorac Soc 5(5):623\u2013630","journal-title":"Proc Am Thorac Soc"},{"key":"394_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1477-7525-3-56","volume":"3","author":"E Stahl","year":"2005","unstructured":"Stahl E, Lindberg A, Jansson SA, Ronmark E, Svensson K, Andersson F et al (2005) Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 3:56","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"394_CR34","doi-asserted-by":"publisher","first-page":"00141","DOI":"10.1183\/23120541.00141-2018","volume":"4","author":"RP Baughman","year":"2018","unstructured":"Baughman RP, Barriuso R, Beyer K, Boyd J, Hochreiter J, Knoet C et al (2018) Sarcoidosis: patient treatment priorities. ERJ Open Res 4(4):00141\u201302018","journal-title":"ERJ Open Res"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-020-00394-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T23:25:31Z","timestamp":1632612331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-020-00394-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,26]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1007\/s00408-020-00394-7","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,26]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Janssen provided financial support for the conduct of the research and\/or preparation of the article and to briefly describe the role of the sponsor(s). Co-authors KL, YW, and EB are employees of Janssen and were part of team involved in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. JD and RB received grant funding from Janssen as participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}